Cetera Advisor Networks LLC Ascendis Pharma A/S Transaction History
Cetera Advisor Networks LLC
- $0
- Q1 2024
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
307Shares Held
64.4MCall Options Held
357KPut Options Held
107K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.12 Billion35.1% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.26MShares$1.09 Billion4.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.11MShares$1.05 Billion13.88% of portfolio
-
Janus Henderson Group PLC London, X04.32MShares$892 Million0.41% of portfolio
-
Lombard Odier Asset Management (Europe) LTD London, X04.27MShares$881 Million0.89% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.5B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...